We are live on ! Find out more
LPNT

LifePoint Health, Inc.
LPNT

Delisted

LPNT was delisted on the 15th of November, 2018.

235 hedge funds and large institutions have $2.71B invested in LifePoint Health, Inc. in 2014 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 63 increasing their positions, 87 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 22

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

13% more capital invested

Capital invested by funds: $2.39B → $2.71B (+$321M)

11% more funds holding

Funds holding: 212235 (+23)

26% less call options, than puts

Call options by funds: $862K | Put options by funds: $1.16M

28% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 87

Holders
235
Holders Change
+23
Holders Change %
+10.85%
% of All Funds
6.75%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.14%
New
47
Increased
63
Reduced
87
Closed
22
Calls
$862K
Puts
$1.16M
Net Calls
-$300K
Net Calls Change
+$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Envestnet Asset Management
226
Envestnet Asset Management
Illinois
$3K +$2.88K +49 New
WEC
227
Winslow Evans & Crocker
Massachusetts
$2.24K
PTC
228
Private Trust Company
Ohio
$1K -$59 -1 -5%
MWP
229
MYCIO Wealth Partners
Pennsylvania
$1K
S
230
SignatureFD
Georgia
$1K +$704 +12 New
PMAM
231
Picton Mahoney Asset Management
Ontario, Canada
$981 +$927K +15,800 New
CRAM
232
Claren Road Asset Management
New York
-$30M -550,000 Closed
PC
233
PointState Capital
New York
-$13.6M -250,000 Closed
CM
234
Corvex Management
New York
-$8.44M -154,759 Closed
GAM
235
Goldentree Asset Management
New York
-$7.97M -146,100 Closed
BCMNY
236
Buckingham Capital Management (New York)
New York
-$5.78M -106,010 Closed
BGIM
237
Brandywine Global Investment Management
Pennsylvania
-$5.66M -103,790 Closed
OAM
238
Oxford Asset Management
United Kingdom
-$4.44M -81,468 Closed
State of Tennessee, Department of Treasury
239
State of Tennessee, Department of Treasury
Tennessee
-$3.88M -71,200 Closed
BCMU
240
BlueCrest Capital Management (UK)
Guernsey
-$2.69M -49,317 Closed
WA
241
Whitebox Advisors
Minnesota
-$2.64M -48,357 Closed
Fiera Capital (Canada)
242
Fiera Capital (Canada)
Quebec, Canada
-$2.14M -39,200 Closed
D.E. Shaw & Co
243
D.E. Shaw & Co
New York
-$1.2M -21,971 Closed
Nomura Asset Management
244
Nomura Asset Management
Japan
-$719K -13,180 Closed
SCA
245
SAC Capital Advisors
Connecticut
-$573K -10,504 Closed
Jane Street
246
Jane Street
New York
-$472K -8,644 Closed
CIBC Asset Management
247
CIBC Asset Management
Ontario, Canada
-$361K -6,611 Closed
SIM
248
Spark Investment Management
New York
-$332K -6,100 Closed
DCM
249
Delta Capital Management
New Jersey
-$266K -4,870 Closed
CMBA
250
C.M. Bidwell & Associates
Hawaii
-$226K -4,150 Closed

LPNT Hedge Fund Activity: Q2 2014 in Review

235 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in LifePoint Health, Inc. (LPNT) for Q2 2014, worth a combined $2.71B — up 13% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LPNT positions and 22 closed out — a net gain of 25 holders — while 63 added to existing stakes and 87 trimmed.

The largest buyer was Ameriprise, adding an estimated $86.5M. The largest seller was Glenview Capital Management, cutting an estimated $165M.

  • 235 institutional investors held LifePoint Health, Inc. (LPNT) as of Q2 2014, up from 212 in Q1 2014.
  • Funds reported $2.71B of LifePoint Health, Inc. stock for Q2 2014, up 13% quarter-over-quarter.
  • 47 funds opened new LifePoint Health, Inc. positions in Q2 2014 and 22 closed out, a net change of +25 holders.
  • The largest LifePoint Health, Inc. buyer in Q2 2014 was Ameriprise, an estimated $86.5M added.
  • The largest LifePoint Health, Inc. seller in Q2 2014 was Glenview Capital Management, an estimated $165M sold.

Based on aggregated 13F filings for Q2 2014.